IA
OREX

IFP Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History

IFP Advisors’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed – – 4290
2018
Q1 		$0 Hold
100
– – ﹤0.01% 3940
2017
Q4 		$0 Sell
100
-10
-9% -$16 ﹤0.01% 4430
2017
Q3 		$0 Hold
110
– – ﹤0.01% 4424
2017
Q2 		$0 Hold
110
– – ﹤0.01% 4417
2017
Q1 		$0 Hold
110
– – ﹤0.01% 4358
2016
Q4 		$0 Hold
110
– – ﹤0.01% 4350
2016
Q3 		$0 Hold
110
– – ﹤0.01% 4267
2016
Q2 		$0 Buy
+110
New +$497 ﹤0.01% 4330
2016
Q1 		– Sell
-10
Closed – – 4478
2015
Q4 		$0 Buy
+10
New +$238 ﹤0.01% 3956

Other funds holding OREX

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

IFP Advisors's OREX Position: Q2 2018 in Review

IFP Advisors sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 100 shares.

IFP Advisors first reported a position in OREX in Q4 2015 and held it in 9 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • IFP Advisors reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • IFP Advisors sold 100 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • IFP Advisors first reported a position in Orexigen Therapeutics, Inc. in Q4 2015 and held it in 9 quarters.
  • IFP Advisors's Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.